Aprea Therapeutics, Inc.
APRE:NasdaqGS
4.687%
(Fri, 01 Jul 2022 20:00:04 +0000)
Nasdaq Real Time Price
Realtime signal
SELL
BUY
| Long Term Signal | SELL |
|---|---|
| Pivot R2 | 0.81 |
| Pivot R1 | 0.78 |
| Last | 0.775 |
| Pivot S1 | 0.73 |
| Pivot S2 | 0.70 |
| Week52high | 5.89 |
|---|---|
| Week52low | 0.62 |
| Day50MovingAvg | 0.99114 |
| Day200MovingAvg | 2.67471 |
| Beta (5Y Monthly) | |
| PE Ratio (TTM) | 0.00 |
| EPS (TTM) | -1.649 |
| Earnings Date | Aug 10 - Aug 15 |
Recommendation Trend
| Jul | Jun | May | Apr | |
| Strong Buy | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 2 | 2 | 0 |
| Sell | 0 | 0 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 0 | 2 | 3 | 0 |
Upgrade Downgrade History
| HC Wainwright & Co. Mar 16 Maintains |
to Neutral |
|---|---|
| RBC Capital Mar 16 Maintains |
to Sector Perform |
| JP Morgan Aug 20 Downgrade |
Neutral to Underweight |
| Berenberg Aug 16 Downgrade |
Buy to Hold |
| HC Wainwright & Co. Aug 16 Maintains |
to Neutral |
| RBC Capital Aug 13 Maintains |
to Sector Perform |
| Morgan Stanley Aug 13 Downgrade |
Equal-Weight to Underweight |
| RBC Capital Mar 17 Maintains |
to Sector Perform |
| RBC Capital Dec 29 Downgrade |
Outperform to Sector Perform |
| Morgan Stanley Dec 16 Maintains |
to Equal-Weight |